by Jordana Choucair | May 26, 2022 | Life Sciences
The Food and Drug Administration (FDA) released final guidance about importing prescription drugs from Canada for up to two years as part of state programs aimed at bringing down drug costs. The FDA in April began discussions with five states — Florida, Colorado,...
by Jordana Choucair | May 26, 2022 | Life Sciences
The Biden administration said it is taking steps to make Pfizer Inc.’s COVID-19 antiviral treatment more accessible across the country as it prepares for an increase in infections over the summer. The first federally backed test-to-treat site will open today,...
by Jordana Choucair | May 25, 2022 | Life Sciences
Senators Maria Cantwell and Chuck Grassley introduced legislation that would prohibit certain pharmacy benefit managers (PBMs) from engaging in unfair pricing tactics such as “spread pricing” or deceptive claw back payments made to pharmacies. The “Pharmacy Benefit...
by Jordana Choucair | May 25, 2022 | Life Sciences
Pfizer Inc. said it will sell 23 of its patent-protected drugs and vaccines at not-for-profit prices to 45 low-income countries beginning later this year, including treatments for cancer, heart conditions, and autoimmune diseases. In 2020, sales to developing...
by Jordana Choucair | May 24, 2022 | Life Sciences
The U.S. is working to release a vaccine from the nation’s Strategic National Stockpile to combat the global outbreak of monkeypox cases. Per the Centers for Disease Control and Prevention (CDC), there is one confirmed case of monkeypox and four suspected cases...
by Jordana Choucair | May 23, 2022 | Life Sciences
Pfizer and BioNTech’s COVID-19 vaccine was more than 80 percent effective at eliciting a strong immune response in children between the ages of 6 months and 5 years old. Pfizer is seeking an emergency use authorization to vaccinate children five and under. The...
Recent Comments